Howard E. Skipper
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Modeling and Simulation top 1%
- Mathematical Biology Tumor Growth
Papers in
-
- Biochemical and Molecular Research 14
- Cancer therapeutics and mechanisms 10
- DNA and Nucleic Acid Chemistry 9
- Oncology 17
- Cancer Treatment and Pharmacology 7
- Co-authors
- F. M. Schabel (10 shared papers)David P. Rall (1 shared paper)Lars Henning Schmidt (1 shared paper)Emil J. Freireich (1 shared paper)E. A. Gehan (1 shared paper)William S. Wilcox (5 shared papers)S. Paul Perry (1 shared paper)L. Lee Bennett (9 shared papers)
- Journals
- Archives of Biochemistry and Biophysics (9 papers)Cancer (9 papers)Experimental Biology and Medicine (6 papers)Nature (3 papers)Annals of the New York Academy of Sciences (3 papers)
- Partner nations
- United States
In The Last Decade
Howard E. Skipper
86 papers receiving 3.3k citations
Howard E. Skipper's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 660
- Modeling and Simulation 211
- Oncology 1.1k
- Hematology 279
- Physiology 109
Countries citing papers authored by Howard E. Skipper
This map shows the geographic impact of Howard E. Skipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard E. Skipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard E. Skipper more than expected).
Fields of papers citing papers by Howard E. Skipper
This network shows the impact of papers produced by Howard E. Skipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard E. Skipper. The network helps show where Howard E. Skipper may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard E. Skipper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Hit paper breakdown → | 1966 | 1222 |
| 2 | EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. Hit paper breakdown → | 1964 | 631 |
| 3 | 1971 | 191 | |
| 4 | Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. | 1970 | 121 |
| 5 | 1965 | 81 | |
| 6 | Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms. | 1959 | 76 |
| 7 | The effects of chemotherapy on the kinetics of leukemic cell behavior. | 1965 | 67 |
| 8 | Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy. | 1961 | 67 |
| 9 | Observations on inhibition of nucleic acid synthesis resulting from administration of nitrogen mustard, urethan,. colchicine, 2,6-diaminopurine, 8-azaguanine, potassium arsenite, and cortisone. | 1951 | 56 |
| 10 | 1978 | 56 | |
| 11 | Carbamates in the chemotherapy of leukemia. VIII. Overall tracer studies on carbonyl-labeled urethan, methylene-labeled urethan, and methylene-labeled ethyl alcohol. | 1951 | 53 |
| 12 | 1956 | 53 | |
| 13 | Dose intensity versus total dose of chemotherapy: an experimental basis. | 1990 | 50 |
| 14 | A mechanism of resistance to 8-azaguanine. II. Studies with experimental neoplasms. | 1959 | 50 |
| 15 | 1956 | 45 | |
| 16 | Attempts at dual blocking of biochemical events in cancer chemotherapy. | 1954 | 45 |
| 17 | 1986 | 45 | |
| 18 | A mechanism of resistance to 8-azaguanine. I. Microbiological studies on the metabolism of purines and 8 azapurines. | 1959 | 44 |
| 19 | Induced mammary carcinoma in the female rat as a drug evaluation system. | 1966 | 44 |
| 20 | Criteria associated with destruction of leukemia and solid tumor cells in animals. | 1967 | 43 |
About Howard E. Skipper
Howard E. Skipper is a scholar working on Molecular Biology, Oncology, Cancer Research, Organic Chemistry and Biotechnology, having authored 87 papers that have together received 4.1k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (14 papers), Cancer therapeutics and mechanisms (10 papers), DNA and Nucleic Acid Chemistry (9 papers), Cancer Treatment and Pharmacology (7 papers), HIV/AIDS drug development and treatment (6 papers), Cancer Research and Treatments (5 papers), Computational Drug Discovery Methods (5 papers) and Carcinogens and Genotoxicity Assessment (5 papers). The work is most often cited by research in Cancer Research (660 citations), Modeling and Simulation (211 citations), Oncology (1.1k citations), Hematology (279 citations) and Physiology (109 citations). Howard E. Skipper has collaborated with scholars based in United States. Frequent co-authors include F. M. Schabel, David P. Rall, Lars Henning Schmidt, Emil J. Freireich, E. A. Gehan, William S. Wilcox, S. Paul Perry, L. Lee Bennett, Jean Thomson and R W Brockman. Their work appears in journals such as Archives of Biochemistry and Biophysics, Cancer, Experimental Biology and Medicine, Nature and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.